Opinion: The great GLP-1 experiment
People are using the drugs for a range of conditions. Science can’t keep up.
From The Times
May 1, 2026

Online and in doctors’ offices, people are finding that GLP-1s may help with everything from arthritis to addiction to migraines. It’s a new era of D.I.Y. medicine, Julia Belluz writes.

Article Image

Bobby Doherty

Opinion

Science needs to keep up, or use of the drug may spin out of control. →

MORE FROM OPINION

A long, wood-paneled hallway, as in an old-fashioned academic building.

Michael S. Roth

Yale has come up with a surefire way to make a terrible situation worse. →

Nadja Spiegelman, Hasan Piker and Jia Tolentino

Here’s why petty theft might be the new political protest. →

A suited job seeker, résumé in hand, navigates a desert landscape of equally desperate-seeming people.

Jessica Grose

There’s another reason Gen Z can’t find work. →

Get expert analysis of the news and a guide to the big ideas shaping the world.

Sign up for the Opinion Today newsletter

Get expert analysis of the news and a guide to the big ideas shaping the world every weekday morning.

Get it in your inbox

If you received this newsletter from someone else, subscribe here.

Need help? Review our newsletter help page or contact us for assistance.

You received this message because you signed up for updates from The New York Times.

To stop receiving From The Times, unsubscribe. To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings.

Subscribe to The Times

Connect with us on:

facebookxinstagramwhatsapp

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

Zeta LogoAdChoices Logo

The New York Times Company. 620 Eighth Avenue New York, NY 10018